|
|
 |
|
Viewing report
|
|
|
|
India Pharmaceutical Regulatory Report 2010 + Appendix
Pacific Bridge Medical, Jan 2010, Pages: 148
The India Pharmaceutical Regulatory Report comprehensively covers all aspects of pharmaceutical regulations in India. It includes overviews of the laws and procedures on registration, manufacturing, distribution, price control, marketing, research and development, and intellectual property protection. It also includes an overview of the Indian pharmaceutical market and foreign involvement in the market up to 2009. How suited the country is to different kinds of market entry – such as manufacturing, sales, or research – is discussed in relation to the regulatory and market environment. As India’s pharmaceutical market is poised for steady growth, reaching an estimated $11 billion in 2008, understanding of Indian regulatory issues is crucial for success there.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Also available
India Pharmaceutical Regulatory Report 2010
Customers who bought this item also bought
India Pharmaceutical Regulatory Report 2011 + Appendix
India Pharmaceutical Regulatory Report 2011
India Pharmaceutical Regulatory Report 2010
China Pharmaceutical Regulatory Report 2011 + Appendix
China Pharmaceutical Regulatory Report 2011
Contract Research Organizations in Asia 2012
Orphan Drugs in Asia: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market 2012
NeoCardiogenesis- Celebrating The Birth Of Regenerative Cardiology
Emerging Clinical Trial Locations – India: Market Dynamics and the Changing Healthcare and Regulatory Environment
Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials
|
|
|
|
